In the years after surgery, micro- and macronutrient impairments present a significant risk. Dr David Johnson tells you how to identify signs of trouble.

Dr Kaunitz reviews new ACOG guidelines on ultrasound, serum marker testing, and surgical intervention for evaluation of adnexal masses.

Dr Whyte warns us to use caution when prescribing opioids with benzodiazepines. Or better yet, avoid their combined use if possible.

The data are unequivocal. Fetal repair vs postnatal repair of myelomeningocele is better. Period.

Susheel Kodali and Thomas Walther review the data from ACC on TAVR vs surgical valve repair. Is the US catching up with Europe?

Dr Harold Burstein gets an oncologist's behind-the- cameras view of 'Cancer: The Emperor of All Maladies,' from Barak Goodman, director of the Ken Burns documentary.

From artificial hands to tiny organs printed from human cells, 3D printing is here--and transplant science will never be the same.

Drs Kathy Miller, Clifford Hudis, and George Sledge discuss the pros and cons of testing novel breast cancer treatments in the neoadjuvant setting, with special reference to pertuzumab.

Dr David Kerr reports on mounting evidence of the significant antitumor activity of yttrium-90 in hepatic metastatic CRC when Y90 microspheres are delivered via the hepatic artery.

Dr Kathy Miller's preview of SABCS 2014 spotlights key data in triple-negative, HER2+, and local-regional disease as well as the much-anticipated results from the SOFT trial.